ArticleMedicine2025
Identification and experimental validation of copper metabolism-related genes in cervical cancer.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Cervical cancer is a common malignancy which is very harmful to women's health worldwide. Copper metabolism has become research highlight and is expected to be new therapeutic target of cancers, but the copper metabolism related genes connect with cervical cancer remain unclear. This study identified and experimentally verified the copper metabolism-related genes in cervical cancer. First, the gene expression profile of cervical cancer was downloaded from the Gene Expression Omnibus database to identify significantly differentially expressed genes of cervical cancer, and these genes were intersected to copper metabolism data set to screened out copper metabolism related genes in cervical cancer. Then gene ontology and Kyoto Encyclopedia of Gene and Genomes enrichment analysis were conducted, the protein-protein interactions were analyzed using the online database STRING11.0. The Cancer Genome Atlas database was used to validate the screening genes and analyze their diagnostic value. Cervical tissue samples from 8 patients with cervical cancer as the experimental group and 10 patients with benign uterine fibroids as the control group were collected, mRNAs was extracted and quantitative real time polymerase chain reaction was used to verify the selected genes. The Human Protein Atlas database was used to verify the expression of the selected genes, and their immune infiltration was studied based on the The Cancer Genome Atlas database. MiRNA-hub gene network, transcription factor-hub gene network and chemical-hub gene network were constructed by us to accurately investigate the molecular mechanism and potential drugs underlying copper metabolism related genes we screened out in cervical cancer. Aquaporin1 and cyclin-dependent kinases1 were the copper metabolism-related genes in cervical cancer we screened out by bioinformatics methods and then validated by clinical samples. Aquaporin1 and cyclin-dependent kinases1 could play an important role in the mechanism of cervical cancer and could be targets of cervical cancer concerning copper metabolism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.